Comparison of in vivo effects of calcitonin, risedronate and raloxifene
Salih Özgöçmen(Tokat Gaziosmanpaşa Üniversitesi), Zahide Yılmaz, Hüseyin Kaya(Fırat University), Ersin Fadıllıoğlu(Inonu University)
Annals of the Rheumatic Diseases
January 1, 2006
Cited by 0
Related Papers
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
|Annals of the Rheumatic Diseases|2017|1.6k
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
|Annals of the Rheumatic Diseases|2011|988
Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
|Annals of the Rheumatic Diseases|2015|268
Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis
|Molecular and Cellular Biochemistry|2006|204
Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin‐induced oxidative damage to liver in rat
|Cell Biochemistry and Function|2006|147